HLA I类抗体与镰状细胞病儿童HLA相合造血干细胞移植中的血小板输注支持
本研究在多中心回顾性分析45例接受HLA相合造血干细胞移植的镰状细胞病患儿,检测移植前HLA I类抗体。
要点
- 移植前HLA I类抗体阳性与血小板输注需求增加相关。
- 抗体阳性患儿急性GVHD发生率显著升高。
- 该关联在控制预处理方案后仍显著。
核心结论
- 移植前HLA I类同种免疫与儿童镰状细胞病HLA相合造血干细胞移植中血小板输注支持增加及急性GVHD相关。
研究设计与样本
- 多中心研究,纳入45例接受HLA相合造血干细胞移植的镰状细胞病患儿,检测移植前HLA I类抗体。
主要发现
- 45例中13例(29%)HLA I类抗体筛查阳性。
- 控制预处理方案后,血小板输注关联仍显著。
- 在同种免疫患者中,群体反应性抗体与血小板输注次数无关联。
临床怎么用
- 对拟行HLA相合移植的镰状细胞病患儿,移植前可考虑筛查HLA I类抗体以评估血小板输注需求和GVHD风险。
局限性
- 样本量较小(45例),需进一步研究探讨该关联的病理生物学机制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The relevance of donor-specific human leukocyte antigen (HLA) antibodies in HLA-mismatched haematopoietic cell transplant (HCT) is known, but the importance of HLA antibodies in HLA-matched HCT is unclear. We hypothesized that HLA antibodies detected before HCT would cause platelet transfusion refractoriness during HCT and investigated this in a multi-centre study. Pre-HCT samples from 45 paediatric patients with sickle cell disease (SCD) undergoing HLA-matched HCT were tested for HLA class I antibodies. The number of platelet transfusions received before day +45 was compared between those with and without antibodies. Thirteen of 45 (29%) patients had a positive HLA class I antibody screen, and these patients received significantly more platelet transfusions than patients without antibodies (median 19 vs. 7·5, P = 0·028). This platelet transfusion association remained significant when controlling for conditioning regimen. Among alloimmunized patients, there was no association between the panel-reactive antibody and the number of platelet transfusions. Patients with HLA class I antibodies also had a higher incidence of acute graft-versus-host disease (GVHD): 6/13 (46%) vs. 3/32 (9%), P = 0·011. Pre-HCT HLA class I alloimmunization is associated with increased platelet transfusion support and acute GVHD in paediatric HLA-matched HCT for SCD. Further studies are needed to investigate the pathobiology of this association.
引用
- Nickel RS, Horan JT, Abraham A, et al. Human leukocyte antigen (HLA) class I antibodies and transfusion support in paediatric HLA-matched haematopoietic cell transplant for sickle cell disease. Br J Haematol. 2019. PMID: 31674662. doi:10.1111/bjh.16298
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。